Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Plavix commercial rights transferred in Japan

July 7, 2005

Fujisawa scientists discover selective and orally active IP receptor agonist

July 5, 2005

Factor Xa inhibitors, PAI-1 inhibitors in early development

July 5, 2005

Bayer to study longer-acting Kogenate product in phase I

July 4, 2005

PEGylated dipetarudin displays enhanced pharmacokinetics

June 17, 2005

New data on the pharmacokinetics of dabigatran etexilate in humans

June 15, 2005

NIP-004: Novel thrombopoietin mimetic small-molecule compound

June 14, 2005

Portola and Astellas collaborate in thrombosis and atherosclerosis

June 9, 2005

INS-50589 Antiplatelet well-tolerated, pharmacologically active in phase I study

June 6, 2005

New approval for Arixtra

May 31, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...